自動分析装置の世界市場 - 産業規模、シェア、動向、機会、予測：分析装置別、用途別、地域別、競合別（2019年～2029年）

世界の自動分析装置の市場規模は、2023年に75億2,000万米ドルとなり、2029年までのCAGRは5.25%で、予測期間中に安定した成長が予測されています。

現代のヘルスケア分野では、特に自動分析装置のような技術革新により、技術の進歩が絶えず業務を再構築しています。これらの先進的なデバイスは、世界中の臨床検査業務を根本的に変え、プロセスを最適化し、精度を高め、最終的に患者ケアを向上させています。

自動分析装置は、サンプル調製から分析、結果の解釈まで、多様な検査機能を自動化するために設計された最先端の機器です。臨床化学や血液学から免疫測定や分子診断まで、幅広い用途に対応しています。反復作業を自動化し、人的ミスを最小限に抑えることで、これらの分析装置は検査室の効率と生産性を大幅に向上させます。

自動分析装置の世界市場は近年、様々な要因によって大きく拡大しています。まず、慢性疾患や感染症の蔓延が拡大しているため、迅速で正確な診断ソリューションが求められており、自動分析装置の普及を後押ししています。さらに、人工知能やロボット工学の導入などの技術進歩が、機器の性能や能力を高めることで市場の成長を促進しています。さらに、予防ヘルスケアや個別化医療への関心の高まりが、自動分析装置を含む高度な診断ツールの需要を促進しています。さらに、特に新興市場におけるヘルスケア支出の増加は、ヘルスケアインフラの拡大とともに、市場企業が新たな市場を開拓し、顧客基盤を拡大する有利な機会を生み出しています。

主な市場促進要因

臨床検査自動化への需要の高まり

慢性疾患および感染症の発生率の上昇

主な市場課題

コスト圧力

相互運用性と統合

主な市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の自動分析装置市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 分析装置別（生化学分析装置、免疫系分析装置、血液分析装置）
  • 用途別（創薬、ゲノミクス、プロテオミクス、バイオ分析、分析化学、臨床診断）
  • 企業別（2023年）
  • 地域別
• 市場マップ

第6章 北米の自動分析装置市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 分析装置別
  • 用途別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の自動分析装置市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 分析装置別
  • 用途別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の自動分析装置市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 分析装置別
  • 用途別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の自動分析装置市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 分析装置別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの自動分析装置市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 分析装置別
  • 用途別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併および買収
• 製品の発売
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Hudson Robotics Inc.
• Becton Dickinson and Company
• Synchron
• Agilent Technologies Inc.
• Siemens Healthineers AG
• Tecan Trading AG
• PerkinElmer Inc.
• Honeywell International Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Automated Analyzers Market was valued at USD 7.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. In the contemporary healthcare sector, technological progress continually reshapes operations, particularly with innovations like automated analyzers. These advanced devices have fundamentally altered clinical laboratory practices worldwide, optimizing processes, boosting precision, and ultimately elevating patient care.

Automated analyzers are cutting-edge instruments engineered to automate diverse laboratory functions, spanning sample preparation, analysis, and result interpretation. They cater to a broad spectrum of applications, from clinical chemistry and hematology to immunoassay and molecular diagnostics. By automating repetitive tasks and minimizing human error, these analyzers significantly bolster laboratory efficiency and output.

The global market for automated analyzers has experienced significant expansion in recent years, fueled by various factors. Firstly, the escalating prevalence of chronic and infectious diseases demands swift and accurate diagnostic solutions, driving the uptake of automated analyzers. Additionally, technological advancements, such as the incorporation of artificial intelligence and robotics, have propelled market growth by enhancing instrument performance and capabilities. Furthermore, the increasing focus on preventive healthcare and personalized medicine has spurred demand for advanced diagnostic tools, including automated analyzers. Moreover, the uptick in healthcare spending, particularly in emerging markets, alongside the expansion of healthcare infrastructure, has created lucrative opportunities for market players to tap into new markets and broaden their customer base.

Key Market Drivers

Growing Demand for Laboratory Automation

In the realm of scientific research and diagnostics, precision and efficiency are paramount. Laboratories worldwide are increasingly turning to automation to streamline processes and enhance accuracy. The global market for automated analyzers, fueled by this growing demand for laboratory automation, is witnessing significant expansion. This surge is reshaping the landscape of scientific analysis, offering unprecedented opportunities for innovation and efficiency. Laboratory automation involves the integration of advanced technologies to perform tasks traditionally carried out by humans. From sample preparation to data analysis, automation minimizes human error, reduces turnaround times, and increases throughput. This transformative shift in laboratory workflows has been catalyzed by several factors. Firstly, the escalating complexity of scientific research and diagnostic testing necessitates higher throughput and accuracy. Manual processes are not only time-consuming but also prone to errors, potentially compromising results. Automated analyzers offer precise, reproducible results even in high-volume testing environments, meeting the demands of modern laboratories. Secondly, the advent of high-throughput screening techniques and advancements in robotics and artificial intelligence have made automation increasingly accessible and cost-effective. Laboratories can now automate a wide array of tasks, including sample handling, liquid handling, and data analysis, with greater ease and efficiency. Furthermore, the ongoing digitization of healthcare and laboratory information systems has facilitated seamless integration between automated analyzers and laboratory management software. This interconnectedness enables real-time monitoring, data management, and remote access, empowering laboratories to operate more efficiently and adapt to evolving research and diagnostic needs.

Rising Incidence of Chronic and Infectious Diseases

In recent years, the world has witnessed a significant rise in the prevalence of chronic and infectious diseases, leading to a growing demand for efficient diagnostic solutions. Automated analyzers have emerged as indispensable tools in healthcare facilities worldwide, offering accuracy, speed, and efficiency in diagnosing a wide range of diseases. As the burden of diseases continues to escalate, the global automated analyzers market is experiencing robust growth, driven by the urgent need for advanced diagnostic capabilities.

The increasing incidence of chronic diseases such as diabetes, cardiovascular disorders, cancer, and respiratory ailments has become a pressing global health concern. According to the World Health Organization (WHO), non-communicable diseases account for approximately 71% of all deaths worldwide, with cardiovascular diseases alone responsible for nearly 17.9 million deaths annually. Moreover, infectious diseases, including influenza, HIV/AIDS, tuberculosis, and emerging threats like COVID-19, continue to pose significant challenges to public health systems worldwide. Automated analyzers play a pivotal role in the timely and accurate diagnosis of various diseases. These sophisticated instruments utilize advanced technologies such as immunoassay, clinical chemistry, hematology, molecular diagnostics, and microbiology to analyze biological samples such as blood, urine, and tissue. By automating complex laboratory processes, these analyzers not only enhance diagnostic accuracy but also streamline workflow, reduce human error, and improve turnaround times, ultimately leading to better patient outcomes.

Key Market Challenges

Cost Pressures

Cost considerations pose a significant challenge for both manufacturers and end-users in the automated analyzers market. While advancements in technology have led to improved efficiency and cost-effectiveness, the initial investment required for acquiring automated analyzers can be substantial. Additionally, ongoing maintenance, calibration, and software updates incur additional expenses over the product's lifecycle. Moreover, fierce competition in the market exerts downward pressure on prices, squeezing profit margins and challenging manufacturers to balance affordability with quality and performance.

Interoperability and Integration

In today's interconnected world, interoperability and seamless integration have become essential requirements for automated analyzers to effectively communicate and exchange data with other systems and devices. However, achieving interoperability can be challenging due to the lack of standardized protocols, proprietary technologies, and compatibility issues between different manufacturers' products. Integration with existing infrastructure and laboratory information management systems (LIMS) also presents hurdles, requiring customized solutions and extensive testing to ensure compatibility and data integrity.

Key Market Trends

Technological Advancements

In recent years, the healthcare industry has witnessed a remarkable transformation propelled by technological advancements. Among these advancements, automated analyzers have emerged as a pivotal tool, revolutionizing diagnostic processes and laboratory workflows. The global automated analyzers market is experiencing significant growth, fueled by the relentless pursuit of efficiency, accuracy, and reliability in diagnostic testing across various sectors including healthcare, pharmaceuticals, and research institutions. Automated analyzers encompass a diverse range of instruments designed to automate the analysis of samples such as blood, urine, and tissues. These systems integrate sophisticated technologies such as robotics, artificial intelligence (AI), and advanced sensors to perform a wide array of tests rapidly and with minimal human intervention.

Automation streamlines laboratory workflows by eliminating manual processes, reducing human error, and significantly increasing the throughput of diagnostic tests. Automated analyzers can handle large volumes of samples efficiently, enabling laboratories to process more tests in a shorter time frame without compromising accuracy. Advanced algorithms and high-performance sensors incorporated into automated analyzers ensure precise and consistent results, enhancing the reliability of diagnostic testing. By minimizing variability and standardizing testing procedures, these systems contribute to better clinical outcomes and informed decision-making by healthcare professionals. While the initial investment in automated analyzers may be substantial, the long-term benefits in terms of operational efficiency and resource utilization are significant. Automated systems reduce the need for manual labor, minimize sample wastage, and optimize reagent usage, ultimately leading to cost savings for laboratories and healthcare facilities. The versatility of automated analyzers enables their application across diverse fields such as clinical diagnostics, drug discovery, forensic analysis, and environmental monitoring. As technological advancements continue to broaden the capabilities of these systems, new opportunities for their utilization in emerging areas of healthcare and research are constantly emerging, further driving market growth. The integration of AI, machine learning, and big data analytics into automated analyzers is revolutionizing diagnostic testing by enabling predictive analytics, personalized medicine, and real-time data insights. These technologies empower automated analyzers to adapt to evolving healthcare needs, optimize testing protocols, and facilitate early disease detection and intervention.

Segmental Insights

Analyzer Insights

Based on analyzer, Immuno-based Analyzers emerged as the dominant player in the global market for Automated Analyzers in 2023. Immuno-based analyzers have emerged as the preferred choice for a wide range of diagnostic applications. Immunoassays are analytical techniques that utilize the specific binding of antibodies to antigens for the detection and quantification of analytes in biological samples. This technology offers unparalleled sensitivity, specificity, and versatility, making it indispensable in clinical diagnostics. Immunoassays are renowned for their exceptional accuracy and sensitivity, allowing for the detection of analytes at very low concentrations. This capability is particularly crucial for diagnosing diseases in their early stages when biomarker levels may be extremely low.

Regional Insights

North America emerged as the dominant region in the global Automated Analyzers market in 2023, holding the largest market share in terms of value. North America boasts a robust ecosystem of research and development, with leading companies continuously investing in cutting-edge technologies to enhance automated analyzer capabilities. From advanced algorithms to integrated systems, these innovations drive market growth and maintain North America's competitive edge. The region is home to world-class healthcare infrastructure, characterized by state-of-the-art laboratories, well-equipped hospitals, and a strong regulatory framework. The presence of renowned healthcare institutions fosters the adoption of automated analyzers, driving market expansion and facilitating widespread access to diagnostic services.

Key Market Players

Thermo Fisher Scientific Inc.

Danaher Corporation

Hudson Robotics Inc.

Becton Dickinson and Company

Synchron

Agilent Technologies Inc.

Siemens Healthineers AG

Tecan Trading AG

PerkinElmer Inc.

Honeywell International Inc.

Report Scope:

In this report, the Global Automated Analyzers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Automated Analyzers Market, By Analyzer:

Biochemistry Analyzers Immuno-based Analyzers Hematology Analyzers

Automated Analyzers Market, By Application:

Drug Discovery Genomics Proteomics Bioanalysis Analytical Chemistry Clinical Diagnostics

Automated Analyzers Market, By Region:

North America
• United States
• Canada
• Mexico
Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
South America
• Brazil
• Argentina
• Colombia
Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Automated Analyzers Market.

Available Customizations:

Global Automated Analyzers market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Automated Analyzers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Analyzer (Biochemistry Analyzers, Immuno-based Analyzers, Hematology Analyzers)
  • 5.2.2. By Application (Drug Discovery, Genomics, Proteomics, Bioanalysis, Analytical Chemistry, Clinical Diagnostics)
  • 5.2.3. By Company (2023)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Automated Analyzers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Analyzer
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Automated Analyzers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Analyzer
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Automated Analyzers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Analyzer
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Automated Analyzers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Analyzer
      • 6.3.3.2.2. By Application

7. Europe Automated Analyzers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Analyzer
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Automated Analyzers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Analyzer
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Automated Analyzers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Analyzer
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Automated Analyzers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Analyzer
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Automated Analyzers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Analyzer
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Automated Analyzers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Analyzer
      • 7.3.5.2.2. By Application

8. Asia-Pacific Automated Analyzers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Analyzer
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Automated Analyzers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Analyzer
      • 8.3.1.2.2. By Application
  • 8.3.2. India Automated Analyzers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Analyzer
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Automated Analyzers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Analyzer
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Automated Analyzers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Analyzer
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Automated Analyzers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Analyzer
      • 8.3.5.2.2. By Application

9. South America Automated Analyzers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Analyzer
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Automated Analyzers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Analyzer
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Automated Analyzers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Analyzer
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Automated Analyzers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Analyzer
      • 9.3.3.2.2. By Application

10. Middle East and Africa Automated Analyzers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Analyzer
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Automated Analyzers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Analyzer
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Automated Analyzers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Analyzer
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Automated Analyzers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Analyzer
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Danaher Corporation
• 14.3. Hudson Robotics Inc.
• 14.4. Becton Dickinson and Company
• 14.5. Synchron
• 14.6. Agilent Technologies Inc.
• 14.7. Siemens Healthineers AG
• 14.8. Tecan Trading AG
• 14.9. PerkinElmer Inc.
• 14.10. Honeywell International Inc.

15. Strategic Recommendations

16. About Us & Disclaimer